Mergers & Acquisitions - Par Pharmaceutical

Filter

Current filters:

Par Pharmaceutical

Popular Filters

TPG to acquire Par Pharma for $1.9 billion

17-07-2012

Par Pharmaceutical (NYSE: PRX), a USA-based maker of generic drugs and niche innovative proprietary pharmaceuticals,…

GenericsMergers & AcquisitionsPar PharmaceuticalTPG

Back to top